Status:
COMPLETED
Animal-Assisted Therapy for Hospitalized Heart Failure Patients
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Pet Care Trust
Conditions:
Heart Failure
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Effects of complementary therapies on heart failure, a leading cause of hospitalization, are unknown. Animal-assisted therapy improves physiological and psychosocial variables in healthy and hypertens...
Detailed Description
Context: Effects of complementary therapies on heart failure, a leading cause of hospitalization, are unknown. Animal-assisted therapy improves physiological and psychosocial variables in healthy and ...
Eligibility Criteria
Inclusion
- diagnosis of heart failure requiring medical management with an indwelling pulmonary artery catheter
- age between 18 and 80 years
- ability to read, write, and speak English
- mental status: alert and oriented to person, place, and time
- SVR greater than 1200 dyne · sec · cm-5 at least once within 12 hours from the start of data collection
Exclusion
- SVR less than 1200 dyne · sec · cm-5
- allergies to dogs
- immunosuppression, defined as a white blood cell count of less than 4500 cells/mm3
- infection as determined by an elevated white blood cell count exceeding 11,000 cells/mm3
- body temperature greater than 38ºC
- decreased level of consciousness
Key Trial Info
Start Date :
November 1 2001
Trial Type :
INTERVENTIONAL
End Date :
July 1 2004
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT00391456
Start Date
November 1 2001
End Date
July 1 2004
Last Update
June 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Medical Center
Los Angeles, California, United States, 90095